<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the concentration of tacrolimus in aqueous humor, and serum of patients with ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease after topical application in 11 patients </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> received 1 drop of isotonic tacrolimus solution 0.3% every 6 hours for 3 days </plain></SENT>
<SENT sid="2" pm="."><plain>The mean tacrolimus concentration in the aqueous and serum, as measured by microparticle enzyme immunoassay, were 12.49 and 0.76 ng/mL, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Tacrolimus may be a promising treatment modality in <z:hpo ids='HP_0012122'>anterior uveitis</z:hpo> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease by topical application </plain></SENT>
</text></document>